menu
    • menu
    [{"orgOrder":0,"company":"TORL BioTherapeutics","sponsor":"Deep Track Capital","pharmaFlowCategory":"D","therapeuticArea":"Oncology","country":"U.S.A","productType":"Large molecule","year":"2024","type":"Series B Financing","leadProduct":"TORL-1-23","moa":"","graph1":"Oncology","graph2":"Phase I","graph3":"TORL BioTherapeutics","amount2":0.16,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Oncology","amount2New":0.16,"dosageForm":"","sponsorNew":"TORL BioTherapeutics \/ Deep Track Capital","highestDevelopmentStatusID":"6","companyTruncated":"TORL BioTherapeutics \/ Deep Track Capital"}]

    Find Clinical Drug Pipeline Developments & Deals by TORL BioTherapeutics

    Menu

    TORL BioTherapeutics

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            TORL BioTherapeutics

                            Country arrow
                            Duphat
                            Not Confirmed

                            TORL BioTherapeutics

                            Country arrow
                            Duphat
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : TORL-1-23

                            Therapeutic Area : Oncology

                            Study Phase : Phase I

                            Sponsor : Deep Track Capital

                            Deal Size : $158.0 million

                            Deal Type : Series B Financing

                            DEALS_DEV arrow-down

                            TORL BioTherapeutics Secures $158 Million for Novel ADC Oncology Pipeline

                            Details : The financing will continue clinical development of TORL-1-23, a potentially best-in-class ADC for Claudin 6 positive tumors, through Phase 1 and pivotal Phase 2 trials.

                            Brand Name : TORL-1-23

                            Molecule Type : Large molecule

                            Upfront Cash : Undisclosed

                            April 10, 2024

                            Lead Product(s) : TORL-1-23

                            Therapeutic Area : Oncology

                            Highest Development Status : Phase I

                            Sponsor : Deep Track Capital

                            Deal Size : $158.0 million

                            Deal Type : Series B Financing

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth